Sales Performance - Fourth quarter sales increased by 2% to $761 million, while full-year sales rose by 1% to $3,260 million, with foreign exchange contributing a favorable impact of 3% in Q4 and 1% for the full year [4]. - Sales for Q4 2025 reached $760.6 million, a slight increase from $746.5 million in Q4 2024, while total sales for the year were $3,260.2 million compared to $3,240.4 million in 2024, reflecting a year-over-year growth of 0.6% [24]. - Total sales for Q4 2025 reached $760.6 million, a 1.9% increase from $746.5 million in Q4 2024 [33]. Earnings and EPS - Full-year 2025 GAAP EPS was $0.89, down from $1.84 in the prior year, while adjusted EPS increased by 6% to $2.82 compared to $2.66 in 2024 [3][4]. - Fourth quarter adjusted EPS of $0.56 represents a 14% growth year-over-year, driven by organic sales growth in the Specialty Engineered Materials segment [4]. - Earnings per share (EPS) for Q4 2025 was $0.18, down from $0.53 in Q4 2024, with diluted EPS for the year at $0.89 compared to $1.84 in 2024, reflecting a decline of 51.6% [24]. - The first quarter adjusted EPS is projected to be $0.81, reflecting a 7% increase compared to the prior year quarter [8]. - For 2026, adjusted EPS is projected to range from $2.93 to $3.17, indicating a growth of 4% to 12% over 2025 [4][8]. Cash Flow and Capital Expenditures - The company generated strong operating cash flow of $302 million for the full year 2025, which supported debt repayment of $150 million [4]. - Net cash provided by operating activities for the year was $301.6 million, compared to $256.8 million in 2024, reflecting an increase of 17.4% [30]. - Capital expenditures for 2025 were $106.6 million, down from $121.9 million in 2024, indicating a reduction of 12.5% [30]. - The company expects to deliver free cash flow exceeding $200 million in 2026, providing greater flexibility for future cash deployment [8]. Profitability Metrics - Adjusted EBITDA margin expanded by 50 basis points to 16.7% for the full year 2025, supported by productivity initiatives [4][6]. - The full-year adjusted EBITDA is expected to be between $555 million and $585 million, representing a growth of 2% to 7% [8]. - Adjusted gross margin as a percentage of sales improved to 32.3% in Q4 2025, compared to 31.6% in Q4 2024 [35]. - Adjusted operating income for Q4 2025 was $73.0 million, up from $65.2 million in Q4 2024, representing a 2.3% increase in operating margin [35]. - Adjusted EBITDA for the year ended 2025 was $544.6 million, compared to $526.4 million in 2024, indicating a 3.9% year-over-year growth [35]. Income and Expenses - Net income attributable to Avient common shareholders for Q4 2025 was $16.9 million, significantly lower than $48.3 million in Q4 2024, with annual net income at $81.9 million compared to $169.5 million in 2024, a decrease of 51.7% [24]. - Operating income for the year ended 2025 was $203.5 million, down from $329.3 million in 2024 [33]. - Selling and administrative expenses increased to $190.0 million in Q4 2025 from $173.9 million in Q4 2024 [33]. - The company reported a net loss attributable to common shareholders of $20.2 million for Q1 2025, with an adjusted net income of $70.0 million [35]. Special Items and Restructuring - The company reported special items impacting net income, with a total impact of $(19.3) million for Q4 2025, compared to $18.0 million in Q4 2024, highlighting the financial restructuring efforts [26]. - Special items before tax for Q4 2025 amounted to $24.3 million, compared to a negative $23.9 million in Q4 2024 [35]. Asset and Liability Overview - Total assets as of December 31, 2025, were $6,025.6 million, up from $5,811.1 million in 2024, representing an increase of 3.7% [28]. - Total liabilities increased to $3,639.3 million in 2025 from $3,481.5 million in 2024, indicating a rise of 4.5% [28].
Avient (AVNT) - 2025 Q4 - Annual Results